1. Home
  2. DSY vs ANL Comparison

DSY vs ANL Comparison

Compare DSY & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DSY

Big Tree Cloud Holdings Limited Ordinary Shares

N/A

Current Price

$3.07

Market Cap

16.6M

Sector

N/A

ML Signal

N/A

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

N/A

Current Price

$9.00

Market Cap

350.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
DSY
ANL
Founded
2020
2004
Country
China
Cayman Islands
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
16.6M
350.9M
IPO Year
2023
2022

Fundamental Metrics

Financial Performance
Metric
DSY
ANL
Price
$3.07
$9.00
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$16.00
AVG Volume (30 Days)
78.6K
208.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.48
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.88
52 Week High
$4.03
$12.09

Technical Indicators

Market Signals
Indicator
DSY
ANL
Relative Strength Index (RSI) 64.89 55.38
Support Level $2.80 $1.37
Resistance Level $4.01 $10.15
Average True Range (ATR) 0.36 0.97
MACD 0.00 -0.27
Stochastic Oscillator 73.40 56.12

Price Performance

Historical Comparison
DSY
ANL

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, distribution, and sales of personal care products and other consumer goods. Operating under a consumer-to-manufacturer and merchant (C2M) model, the company integrates online and offline operations to enhance customer engagement, product innovation, and marketing efficiency. Specializing in feminine hygiene products such as sterilized feminine pads, menstrual pants, and related items, Big Tree Cloud leverages its platform to consolidate resources within China's personal care industry while building a consumer community that provides direct feedback and product insights.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: